Cargando…
The Effect of Substituted Benzene-Sulfonamides and Clinically Licensed Drugs on the Catalytic Activity of CynT2, a Carbonic Anhydrase Crucial for Escherichia coli Life Cycle
Proteins are relevant antimicrobial drug targets, and among them, enzymes represent a significant group, since most of them catalyze reactions essential for supporting the central metabolism, or are necessary for the pathogen vitality. Genomic exploration of pathogenic and non-pathogenic microorgani...
Autores principales: | Del Prete, Sonia, De Luca, Viviana, Bua, Silvia, Nocentini, Alessio, Carginale, Vincenzo, Supuran, Claudiu T., Capasso, Clemente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312386/ https://www.ncbi.nlm.nih.gov/pubmed/32545297 http://dx.doi.org/10.3390/ijms21114175 |
Ejemplares similares
-
Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors
por: Rogato, Alessandra, et al.
Publicado: (2019) -
Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei
por: Vullo, Daniela, et al.
Publicado: (2017) -
Effect of Sulfonamides and Their Structurally Related Derivatives on the Activity of ι-Carbonic Anhydrase from Burkholderia territorii
por: De Luca, Viviana, et al.
Publicado: (2021) -
Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii
por: Del Prete, Sonia, et al.
Publicado: (2020) -
The gram-negative bacterium Escherichia coli as a model for testing the effect of carbonic anhydrase inhibition on bacterial growth
por: De Luca, Viviana, et al.
Publicado: (2022)